Skip to main content
Clinical Trials/NCT01757977
NCT01757977
Completed
Not Applicable

A Comparison of the Performance of Standard Double Lumen Tubes With Vivasight DL™ Double Lumen Tubes for Lung Isolation in Patients Undergoing Thoracic Surgery

John Laffey1 site in 1 country25 target enrollmentAugust 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Performance and Safety of an Airway Management Device
Sponsor
John Laffey
Enrollment
25
Locations
1
Primary Endpoint
Adequacy of optical view obtained to confirm optimal tube position.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The investigators have performed a number of studies on novel airway devices. In this randomized controlled trial he investigators would like to compare the performance of a new double-lumen endotracheal tube incorporating internal camera (Vivasight DL) with a standard double lumen tube.

Detailed Description

Single lung ventilation is frequently carried out to facilitate surgery on the lungs and pleura. In most instances this is achieved by insertion of a double-lumen endotracheal tube and then selectively ventilating one lung or both. Precise positioning of these tubes is essential for optimal performance. It has become the standard of care to perform bronchoscopy to confirm tube position. A new double lumen endotracheal tube (Vivasight DL) has recently been developed. It has all the features of a standard double lumen endotracheal tube but also incorporates an internal camera which, when connected to an external screen, allows continuous confirmation of tube position. This is randomized, single blinded controlled trial. The participants will be allocated to two study groups (Vivasight DL or standard DLT), in which the primary airway management device will be respectively Vivasight DL double lumen tube or a standard double lumen endotracheal tube. Clinical Research Ethics Committee approval has been obtained. Suitable participants will be recruited after written informed consent. Standard anesthetic preassessment and anesthesia will be provided. Consenting patients passing the inclusion and exclusion criteria will be randomly allocated to either of the 2 study groups. Protocol for attempts at placement and tube position confirmation will be followed. The investigators will monitor a number of parameters, including time and ease of tube insertion, ability to verify tube position with the primary imaging modality for each group, need to perform tube position adjustment maneuvers, need to use fiberoptic bronchoscope during the case, quality of lung collapse, problems with ventilation and other. The primary hypothesis is that the new Vivasight DL tube system will provide a comparable optical view to the fiberoptic scope view obtained via standard double lumen endotracheal tube in order to confirm optimal position.

Registry
clinicaltrials.gov
Start Date
August 2012
End Date
January 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

John Laffey

Professor of Anaesthesia and Critical Care, Consultant Anaesthetist

University College Hospital Galway

Eligibility Criteria

Inclusion Criteria

  • 16 - 85 yr old patients capable of informed consent
  • ASA (American Society of Anesthesiologists physical status) 1-3
  • non-emergency surgery of expected duration \< 6 hours
  • one-lung ventilation required

Exclusion Criteria

  • BMI \> 35
  • expected difficult airway
  • Mallampati score \>2
  • increased risk of aspiration
  • upper airway or upper GI problems
  • live pregnancy

Outcomes

Primary Outcomes

Adequacy of optical view obtained to confirm optimal tube position.

Time Frame: within 60 minutes of commencement of general anesthesia

The hypothesis is that the new Vivasight DL tube system will provide a comparable optical view to the fiberoptic scope view obtained via standard double lumen endotracheal tube in order to confirm optimal position.

Secondary Outcomes

  • Time to confirmation of tube position(within 60 minutes of commencement of general anesthesia)
  • Operator rated Device Difficulty Score(within 60 minutes of commencement of general anesthesia)
  • Time from initial laryngoscopy to passing tube through vocal cords(Within 60 minutes of commencement of general anesthesia)
  • rate of malposition(within 15 hours of commencement of general anesthesia)
  • need to pass a fiberoptic bronchoscope during case(within 15 hours of commencement of general anesthesia)
  • presence of blood at the carina immediately post intubation(within 60 minutes of commencement of general anesthesia)

Study Sites (1)

Loading locations...

Similar Trials